» Articles » PMID: 38146580

Delayed Diagnosis of Primary Hyperparathyroidism: A Case Report

Overview
Journal Cureus
Date 2023 Dec 26
PMID 38146580
Authors
Affiliations
Soon will be listed here.
Abstract

Primary hyperparathyroidism (PHPT) is characterized by an elevation in serum calcium levels, sometimes leading to aggravated clinical conditions, namely nephrolithiasis, nephrocalcinosis, and/or fractures. A 55-year-old patient was admitted to the hospital with acute obstructive pyelonephritis in March 2021, having another episode one year later. Initial blood and urine analysis detected inflammatory markers, namely C-reactive protein, and the presence of leucocytes and blood in the urine. The renal computed tomography scan exhibited renal asymmetry, nephrocalcinosis, and multiple kidney stones. The patient was scheduled for a follow-up one year later to perform blood and urine analysis to uncover the cause of nephrocalcinosis, displaying high serum calcium and parathyroid hormone (PTH) levels. The thyroid ultrasound revealed a parathyroid adenoma, which was removed through a right lower parathyroidectomy, improving the symptoms. The clinical condition described here is an atypical manifestation of this disease because PHPT is normally asymptomatic. In the present case study, nephrocalcinosis and nephrolithiasis were strong indicators of the underlying disease. However, the delay in the follow-up consultation resulted in complications for the patient, such as microabscesses in the kidneys, which could lead to reduced renal function in the future. Early detection of key aspects of the disease could avoid further complications and suffering for the patient. For example, the family physician's follow-up of the patient's condition could surpass the waiting time between consultations with different specialties, and promote early treatment.

References
1.
Kowalski G, Bula G, Zadlo D, Gawrychowska A, Gawrychowski J . Primary hyperparathyroidism. Endokrynol Pol. 2020; 71(3):260-270. DOI: 10.5603/EP.a2020.0028. View

2.
Munoz-Torres M, Garcia-Martin A . Primary hyperparathyroidism. Med Clin (Barc). 2017; 150(6):226-232. DOI: 10.1016/j.medcli.2017.07.020. View

3.
Bilezikian J, Khan A, Silverberg S, Fuleihan G, Marcocci C, Minisola S . Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop. J Bone Miner Res. 2022; 37(11):2293-2314. DOI: 10.1002/jbmr.4677. View

4.
Neves M, Santos R, Ohe M . Surgery for primary hyperparathyroidism. Arch Endocrinol Metab. 2022; 66(5):678-688. PMC: 10118824. DOI: 10.20945/2359-3997000000557. View

5.
Silva B, Cusano N, Bilezikian J . Primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab. 2018; 32(5):593-607. DOI: 10.1016/j.beem.2018.09.004. View